News
INFU
7.61
-3.30%
-0.26
Weekly Report: what happened at INFU last week (0415-0419)?
Weekly Report · 3d ago
Weekly Report: what happened at INFU last week (0408-0412)?
Weekly Report · 04/15 12:22
Infusion Therapy: A Comprehensive Analysis of InfusionSystem Holdings, Inc.'s Annual Report
Press release · 04/10 18:13
Weekly Report: what happened at INFU last week (0401-0405)?
Weekly Report · 04/08 12:28
InfuSystem gets non-compliance notice from NYSE American
InfuSystem gets non-compliance notice from NYSE American. The company's inability to to timely file annual report on Form 10-K for the year ended December 31. InfuSystem Holdings, Inc. (INFU) stock is down 1.5%.
Seeking Alpha · 04/03 10:46
InfuSystem Faces NYSE Compliance Hurdles and Delisting Risk
TipRanks · 04/03 10:42
InfuSystem Gets Notice From NYSE American Regarding Late Filing Of Annual Report On Form 10-K
Benzinga · 04/03 10:33
INFUSYSTEM RECEIVES NOTICE FROM NYSE AMERICAN REGARDING LATE FILING OF ANNUAL REPORT ON FORM 10-K
Reuters · 04/03 10:32
Weekly Report: what happened at INFU last week (0325-0329)?
Weekly Report · 04/01 12:24
Weekly Report: what happened at INFU last week (0318-0322)?
Weekly Report · 03/25 12:28
Weekly Report: what happened at INFU last week (0311-0315)?
Weekly Report · 03/18 12:26
Analysts Are Bullish on Top Healthcare Stocks: InfuSystem Holdings, Inc. (INFU), Aquestive Therapeutics (AQST)
InfuSystem Holdings, Inc. (INFU), Aquestive Therapeutics (AQST) and OmniAb (OABI) have 3 analysts with bullish sentiments on the Healthcare sector. 3 analysts have maintained a Buy rating on InfuSystem and a Buy on OmniAb. The 3 stocks are most likely to make moves following insider activities.
TipRanks · 03/15 13:01
InfuSystem GAAP EPS of $0.00 in-line, revenue of $31.77M beats by $1.77M
Seeking Alpha · 03/14 10:32
InfuSystems Holdings Q4 Sales $31.77M Beat $30.00M Estimate
Benzinga · 03/14 10:31
Press Release: InfuSystem Announces Operational -2-
Device Solutions gross profit during the fourth quarter of 2023 was $4.1 million. Device Solutions gross margin was 32.8% during the current quarter, 6.0% lower than the prior year period. The decrease was due to an increase in labor costs related to the rapid on-boarding of the master services agreement. During the year ended December 31, 2023, operating cash flow decreased by 36%.
Dow Jones · 03/14 10:30
Press Release: InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2023
InfuSystem Holdings, Inc. Reports financial results for the fourth quarter and full year ended December 31, 2023. The company reported record revenue of $125.8 million, an increase of 14% over the same period. Net revenues for the year increased 13% and Adjusted EBITDA was up 8%. The company is a leading national health care service provider for durable medical equipment manufacturers.
Dow Jones · 03/14 10:30
*InfuSystems 4Q Rev $31.8M >INFU
Dow Jones · 03/14 10:30
*InfuSystems 4Q EPS 1c >INFU
Dow Jones · 03/14 10:30
*InfuSystems 4Q Net $72,000 >INFU
Dow Jones · 03/14 10:30
Earnings Scheduled For March 14, 2024
Pharming is projected to report earnings for its fourth quarter. Dick's Sporting Goods is expected to report quarterly earnings at $3.35 per share on revenue of $817.48 million. Other companies expected to release earnings before the bell include Hello Gr, Weibo and Build-A-Bear Workshop.
Benzinga · 03/14 09:52
More
Webull provides a variety of real-time INFU stock news. You can receive the latest news about Infusystem Hld through multiple platforms. This information may help you make smarter investment decisions.
About INFU
InfuSystem Holdings, Inc. is a health care service provider that facilitates outpatient care for durable medical equipment manufacturers and health care providers. The Company’s segments include Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The Company’s core service within its ITS segment is its Oncology Business. The ITS segment supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its DME Services segments core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment; sell treatment-related consumables; and provide biomedical recertification, maintenance and repair services for oncology practices as well as other healthcare site settings.